Barbara A. Bresnahan, MD

Publications

• Long-term Safety in Epstein–Barr Virus–Seropositive Kidney-only Transplant Recipients Treated With Belatacept in Clinical Practice: Final study results from the ENLIST registry

  (Larsen CP, Vincenti F, Kou TD, Shadur CA, Bresnahan B, Jordan SC, Woodle ES, Goes N, Vella J, Wojciechowski D, Polinsky MS, Gomez-Caminero A.) Transplantation Direct. 17 May 2024;10(6):E1644 SCOPUS ID: 2-s2.0-85193943265 05/17/2024

• Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients administered belatacept or cyclosporine in BENEFIT and BENEFIT-EXT.

  (Florman S, Vincenti F, Durrbach A, Abouljoud M, Bresnahan B, Garcia VD, Mulloy L, Rice K, Rostaing L, Zayas C, Calderon K, Meier-Kriesche U, Polinsky M, Yang L, Medina Pestana J, Larsen CP.) Clin Transplant. 2018 Apr;32(4):e13225 PMID: 29461660 SCOPUS ID: 2-s2.0-85043576012 02/21/2018

• Lower prevalence of BK virus infection in African American renal transplant recipients: a prospective study.

  (Sood P, Senanayake S, Sujeet K, Medipalli R, Saad E, Vasudev B, Bresnahan BA, Johnson CP, Hariharan S.) Transplantation. 2012 Feb 15;93(3):291-6 PMID: 22179402 SCOPUS ID: 2-s2.0-84856459284 12/20/2011

• Percussion hemoglobinuria - a novel term for hand trauma-induced mechanical hemolysis: a case report.

  (Vasudev M, Bresnahan BA, Cohen EP, Hari PN, Hariharan S, Vasudev BS.) J Med Case Rep. 2011 Oct 07;5:508 PMID: 21982397 PMCID: PMC3213680 10/11/2011

• Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy.

  (Saad ER, Bresnahan BA, Cohen EP, Lu N, Orentas RJ, Vasudev B, Hariharan S.) Transplantation. 2008 Mar 27;85(6):850-4 PMID: 18360267 SCOPUS ID: 2-s2.0-41149157586 03/25/2008

• BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.

  (Vasudev B, Hariharan S, Hussain SA, Zhu YR, Bresnahan BA, Cohen EP.) Kidney Int. 2005 Oct;68(4):1834-9 PMID: 16164661 SCOPUS ID: 2-s2.0-31644434617 09/17/2005

• Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder.

  (Ganne V, Siddiqi N, Kamaplath B, Chang CC, Cohen EP, Bresnahan BA, Hariharan S.) Clin Transplant. 2003 Oct;17(5):417-22 PMID: 14703923 SCOPUS ID: 2-s2.0-0141886902 01/06/2004

• Post-transplant renal function in the first year predicts long-term kidney transplant survival.

  (Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP.) Kidney Int. 2002 Jul;62(1):311-8 PMID: 12081593 SCOPUS ID: 2-s2.0-0036314948 06/26/2002

• A comparison between recipients receiving matched kidney and those receiving mismatched kidney from the same cadaver donor.

  (Bresnahan BA, Johnson CP, McIntosh MJ, Stablein D, Hariharan S.) Am J Transplant. 2002 Apr;2(4):366-72 PMID: 12118860 SCOPUS ID: 2-s2.0-0036556117 07/18/2002

• Rapid kidney allograft failure in patients with polyoma virus nephritis with prior treatment with antilymphocyte agents.

  (Hussain S, Bresnahan BA, Cohen EP, Hariharan S.) Clin Transplant. 2002 Feb;16(1):43-7 PMID: 11982614 SCOPUS ID: 2-s2.0-0036099364 05/02/2002

• Risk factors for renal allograft survival from pediatric cadaver donors: an analysis of united network for organ sharing data.

  (Bresnahan BA, McBride MA, Cherikh WS, Hariharan S.) Transplantation. 2001 Jul 27;72(2):256-61 PMID: 11477349 SCOPUS ID: 2-s2.0-0034904970 07/31/2001

• Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis.

  (Ahuja M, Cohen EP, Dayer AM, Kampalath B, Chang CC, Bresnahan BA, Hariharan S.) Transplantation. 2001 Apr 15;71(7):896-9 PMID: 11349723 SCOPUS ID: 2-s2.0-0035870629 05/15/2001